A detailed history of Bank Of Montreal transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 7,654 shares of AMPH stock, worth $408,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,654
Previous 7,646 0.1%
Holding current value
$408,723
Previous $335,000 8.66%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $309 - $347
8 Added 0.1%
7,654 $306,000
Q1 2024

May 13, 2024

BUY
$42.85 - $63.45 $8,570 - $12,690
200 Added 2.69%
7,646 $335,000
Q4 2023

Feb 08, 2024

SELL
$44.49 - $62.93 $24,291 - $34,359
-546 Reduced 6.83%
7,446 $460,000
Q3 2023

Nov 01, 2023

SELL
$45.51 - $65.0 $24,757 - $35,360
-544 Reduced 6.37%
7,992 $367,000
Q2 2023

Aug 02, 2023

BUY
$35.77 - $58.38 $40,133 - $65,502
1,122 Added 15.13%
8,536 $490,000
Q1 2023

Jun 13, 2024

BUY
$27.99 - $37.92 $30,565 - $41,408
1,092 Added 14.28%
8,738 $327,000
Q4 2022

Feb 01, 2023

BUY
$27.93 - $31.27 $16,702 - $18,699
598 Added 8.77%
7,414 $207,000
Q3 2022

Nov 10, 2022

BUY
$27.56 - $37.75 $8,846 - $12,117
321 Added 4.94%
6,816 $222,000
Q2 2022

Aug 11, 2022

SELL
$29.79 - $42.29 $194,647 - $276,322
-6,534 Reduced 50.15%
6,495 $223,000
Q1 2022

May 12, 2022

BUY
$22.96 - $36.45 $8,518 - $13,522
371 Added 2.93%
13,029 $477,000
Q4 2021

Feb 11, 2022

SELL
$18.14 - $23.29 $30,094 - $38,638
-1,659 Reduced 11.59%
12,658 $298,000
Q3 2021

Nov 12, 2021

SELL
$17.83 - $21.49 $27,654 - $33,330
-1,551 Reduced 9.77%
14,317 $279,000
Q2 2021

Aug 12, 2021

BUY
$17.11 - $20.92 $271,501 - $331,958
15,868 New
15,868 $331,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.62B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.